# Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery

> **NCT03513406** · PHASE3 · COMPLETED · sponsor: **University of Kansas Medical Center** · enrollment: 7 (actual)

## Conditions studied

- Burns

## Interventions

- **DRUG:** Sugammadex
- **DRUG:** Neostigmine
- **DRUG:** Glycopyrrolate

## Key facts

- **NCT ID:** NCT03513406
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-15
- **Primary completion:** 2023-03-07
- **Final completion:** 2023-03-07
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03513406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03513406, "Comparison of Reversal of Neuromuscular Blockade With Sugammadex Versus Neostigmine Plus Glycopyrolate in Patients Undergoing Burn Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03513406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*